0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessNormal WBNAA is not characteristic of benign MS and is not an early predictor of its course. These patients, therefore, probably benefit from successful compensation and sparing of eloquent regions. Because they may ultimately have a rapid decline once their brain plasticity is exhausted, they may benefit from treatment options offered to more affected patients.
D.J. Rigotti, Oded Gonen, Robert I. Grossman, James S. Babb, Andrea Falini, Béatrice Benedetti, Massimo Filippi (2010). Global<i>N</i>-Acetylaspartate Declines Even in Benign Multiple Sclerosis. , 32(1), DOI: https://doi.org/10.3174/ajnr.a2254.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2010
Authors
7
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.3174/ajnr.a2254
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
